Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferoxamine patch for chronic sickle cell leg ulcers
NCT04058197Phase 2Withdrawn
- Sponsor
- TauTona Group
- Start
- Jul 2020
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of DFO Gel in Cutaneous ulcer, sponsored by TauTona Group. Planned start Jul 2020; status: withdrawn.
02
Drugs
DFO Gel
03
Conditions
Cutaneous ulcer
Beyond the preview
Go deeper on NCT04058197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04058197.